Selected publications
-
Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC.
Journal of the American Academy of Dermatology.
2015
Academic Article
GET IT
Times cited: 95 -
Efficacy and safety of vismodegib in advanced basal-cell carcinoma.
New England Journal of Medicine.
2012
Academic Article
GET IT
Times cited: 741